Schoolgirls to get cervical cancer vaccines from 2014

Speaking during the health budget vote debate in the National Assembly on Wednesday, Motsoaledi said government hoped to negotiate lower prices for the vaccine, which treats the human papilloma virus (HPV) – the major cause of cervical cancer among women.

Quoting experts, he said cervical cancer affected 6 000 South African women a year, 80% of them black. More than half the women affected died of the disease.

While the HPV vaccine presented an opportunity to prevent women from contracting cancer, there were still obstacles to overcome.

"The very bad news is that the prices are prohibitive, at between R500 and R750 a dose, and you need three doses to be covered," he said.

The Bill and Melinda Gates Foundation established the Gates Action for Vaccines and Immunisation to help make the drugs more affordable. South Africa did not qualify because it was "regarded to be too rich".

'Part of our school health programme'
The fact that the Pan American Health Organisation negotiated lower prices for the vaccine for Latin American countries was a good indication South Africa could do the same.

"I am extremely happy to announce that in consultation with the minister of finance and the minister of basic education, we have decided that we shall commence to administer the HPV vaccines as part of our school health programme as from February next year.

"We will enter negotiations in our own right to also be given a fair deal in the interest of the lives of the women of this country," said Motsoaledi.

Since the vaccine only worked fully before girls become sexually active, it would be administered to nine and 10-year-old girls.

However, the roll-out would start only in quintile one, two, three and four schools, covering around 520 000 girls.


'We are not discriminating'
"We are not discriminating against quintile five schools … We are just saying the parents there can afford [the vaccine], and please, they must try and buy it on their own until we are able to cover it."

Motsoaledi appealed to medical aid schemes to cover the vaccines, to help the parents of pupils who would not qualify for the vaccine next year.

The benefits of doing so far outweighed the costs of treating cervical cancer, he said.

"It costs up to R100 000 per patient in the public sector to treat each of the 6 000 cervical cancer patients. I am scared to quote you the figures for the private sector treatment," he said. – Sapa

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever. But it comes at a cost. Advertisers are cancelling campaigns, and our live events have come to an abrupt halt. Our income has been slashed.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years. We’ve survived thanks to the support of our readers, we will need you to help us get through this.

To help us ensure another 35 future years of fiercely independent journalism, please subscribe.

Advertising

Judge trashes entire lockdown regime as constitutionally flawed

The high court ruling will delight gatvol South Africans but is unlikely to stand the test of time

Eusebius McKaiser: Two important lessons to learn about racists

The racially intolerant act to keep black people in “their place”, some even while claiming they're allies
Advertising

press releases

Loading latest Press Releases…

The best local and international journalism

handpicked and in your inbox every weekday